| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 40.671 | 11.329 | 58.158 | 35.050 | - | - |
| Total Income - EUR | - | - | - | - | 40.671 | 11.329 | 58.158 | 37.013 | - | - |
| Total Expenses - EUR | - | - | - | - | 5.653 | 13.468 | 26.662 | 11.877 | - | - |
| Gross Profit/Loss - EUR | - | - | - | - | 35.018 | -2.139 | 31.496 | 25.136 | - | - |
| Net Profit/Loss - EUR | - | - | - | - | 33.805 | -2.253 | 30.461 | 24.785 | - | - |
| Employees | - | - | - | - | 0 | 1 | 1 | 1 | - | - |
Check the financial reports for the company - Bios. Natural. Med. S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 169 | 0 | 0 | 825 | - | - |
| Current Assets | - | - | - | - | 34.891 | 31.142 | 61.064 | 85.986 | - | - |
| Inventories | - | - | - | - | 308 | 613 | 0 | 2.115 | - | - |
| Receivables | - | - | - | - | 0 | 0 | 0 | 0 | - | - |
| Cash | - | - | - | - | 34.583 | 30.529 | 61.064 | 83.871 | - | - |
| Shareholders Funds | - | - | - | - | 33.847 | 30.952 | 60.727 | 85.700 | - | - |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | - | - |
| Debts | - | - | - | - | 1.214 | 189 | 336 | 1.110 | - | - |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | - | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4690 - 4690" | |||||||||
| CAEN Financial Year |
4690
|
|||||||||
Comments - Bios. Natural. Med. S.r.l.